← Issue №15/ week of Oct 11, 2026/Pancreas/Biliary

Validation of Discharge Criteria and Risk Factors for Readmission After Pancreatoduodenectomy.

From GI Signals issue №15: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary retrospective · n=976 · Oct 5, 2026 · J Hepatobil Pancreat Sci · IF 3.8

Validation of Discharge Criteria and Risk Factors for Readmission After Pancreatoduodenectomy.

New evidencepancreatic cancerhealth services
Clinical takeawayNo clinical action yet; consider stricter discharge assessment for patients with postoperative intra-abdominal abscess or CRP ≥ 5.0 mg/dL to reduce readmission risk.
What it foundPatients with postoperative intra-abdominal abscess (OR 2.82) or CRP ≥ 5.0 mg/dL at discharge (OR 3.34) had higher 30-day readmission rates.
ContextConfirms the clinical validity of discharge criteria (independent activities of daily living, adequate oral intake, CRP < 5.0 mg/dL) for pancreatoduodenectomy patients.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Hirano T … Satoi S · Journal of Hepato-Biliary-Pancreatic Sciences · IF 3.8 · PubMed ↗Permalink
← Read the whole of issue №15 Every paper GI Signals surfaces gets a page like this one. All issues